Correction: Masitinib for mild-to-moderate Alzheimer’s disease: results from a randomized, placebo-controlled, phase 3, clinical trial (Alzheimer's Research & Therapy, (2023), 15, 1, (39), 10.1186/s13195-023-01169-x)

AB09004 Study Group Investigators

Research output: Contribution to journalComment/Letter to the editorAcademic


Following publication of the original article [1], the authors identified an error in the author name of Triantafyllos Doskas. The given name and family name were reversed. The incorrect author name is: Doskas Triantafyllos The correct author name is: Triantafyllos Doskas The author group has been updated above and the original article [1] has been corrected.

Original languageEnglish
Article number85
Pages (from-to)85
Number of pages1
JournalAlzheimer's Research & Therapy
Issue number1
Publication statusPublished - Dec 2023
Externally publishedYes

Cite this